This is a guest post from Susan K Finston, President of Finston Consulting. Do you have a response to Susan’s post? […]
Redefining Protein Products – When is a Tail a Leg? Read Post »
Six years ago I built a global biotechnology innovation index, and I have been using it since tracking global biotechnology
Tracking global biotechnology innovation for a sixth year Read Post »
The 1980 Supreme Court case of Diamond v. Chakrabarty was transformative for the biotechnology industry. It saw the Supreme Court
New book by biotechnology pioneer Ananda Chakrabarty – Bugging Cancer Read Post »
In a recent post at In the Pipeline, Derek Lowe answers a reader’s question about how best to promote drug
Building Biotechnology in India – Drugs are not the answer Read Post »
This paper is part of the free Open Access archive of the Journal of Commercial Biotechnology
Festo: The plague continues
Go to paperABSTRACT: This paper reviews the law on the doctrine of equivalence and prosecution history estoppel and explores ho…
This is a guest post by Steve Sapletal, a director in West Monroe Partners‘ M&A practice. Do you have a response to
A lesson learned: how downsizing will allow the life sciences industry to grow Read Post »
I have created a six-hour biotechnology education series at bit.ly/LfbSdS, and I want to highlight the policy discussion here. It is
I have created a six-hour biotechnology education series at bit.ly/LfbSdS, and I want to highlight the policy discussion here. It is
Biotechnology Policy: Balancing Innovation Incentives with Economic Contraints Read Post »
I have created a six-hour biotechnology education series at bit.ly/LfbSdS, and I want to highlight the policy discussion here. It is
On a recent press tour of New Jersey I was introduced to PTC Therapeutics, a fascinating company that is developing
Are Ribosomal Readthrough Drugs the Next Biotech Magic Bullet? Read Post »